IBM's Quantum Ambition Meets Its Mainframe Moment: A Tale of Two Businesses
Published on 07/23/2026 at 12:11 | Redaktion boerse-global.de
The numbers coming out of IBM's second-quarter report tell a story of a company caught between two very different trajectories. On one hand, software revenue is climbing at a respectable 5 percent clip, reaching $7.8 billion. On the other, the infrastructure division is hemorrhaging, with mainframe sales plunging 42 percent and the unit's overall revenue falling 7 percent to $3.8 billion. The net result: total revenue of $17.2 billion, up a meager 1 percent from a year ago.
Yet the market's reaction was anything but measured. On Tuesday, IBM shares suffered their worst single-day decline in corporate history, tumbling 25 percent — a rout that eclipsed even the 23.7 percent drop on Black Monday in October 1987. The stock now trades at around €180, barely a whisker above its 52-week low of €178.52, and sits 38.24 percent below the year's peak. Over the past week alone, the shares have shed 6.06 percent.
A Cannibalization Crisis, Not a Demand Problem
What makes this sell-off particularly unsettling is its root cause. CEO Arvind Krishna didn't blame weak demand. Instead, he pointed to a peculiar dynamic: IBM's own customers are diverting their spending toward hardware — servers, storage, and memory — to lock down scarce infrastructure before prices rise. In an investor letter, Krishna explained that clients rushed to secure capacity in the final weeks of June, reallocating quarterly budgets away from software and consulting.
This is the IBM paradox in its starkest form. The very AI infrastructure boom that the company hoped to profit from as a software and services provider is now eating into its core business. Customers aren't abandoning IBM; they're simply spending their money on the physical building blocks of AI rather than the higher-margin offerings that IBM has been betting its future on.
Should investors sell immediately? Or is it worth buying IBM?
The $10 Billion Quantum Question
Against this backdrop, management's refusal to rethink its most audacious bet stands out. IBM plans to invest more than $10 billion in quantum computing over the next five years, targeting a large-scale, fault-tolerant quantum computer by 2029. That's a staggering commitment for a company whose stock is in freefall and whose CEO has acknowledged execution missteps.
The bull case rests on the idea that the current pain is cyclical — a temporary shift in customer spending patterns rather than a structural loss of competitive advantage. Patient capital, the argument goes, will be rewarded as quantum and AI infrastructure investments eventually pay off. The software division, which now accounts for roughly 45 percent of total revenue, is the linchpin of this thesis. Recurring revenue makes up about 80 percent of software sales, providing a stabilizing floor.
Technical Signals and Analyst Divergence
From a chart perspective, the stock looks deeply oversold. The 14-day relative strength index sits at 29.8, firmly in oversold territory, while the 30-day annualized volatility has surged to nearly 84 percent — an extraordinary reading for a stock long considered a steady dividend play. The analyst consensus still sees a price target of €239.87, implying 33.3 percent upside from current levels.
But the bears have their own compelling narrative. Free cash flow slipped to $2.5 billion in the second quarter, down $300 million from the same period last year. The consulting business, at $5.3 billion in revenue, is stagnating. Skeptics argue that corporate clients are funneling their IT budgets into hardware and storage — often from IBM's competitors — rather than the digital transformation projects that feed the services arm. If that trend persists, the stock's 12-month decline of nearly 25 percent could deepen.
The HashiCorp Wild Card and the Road Ahead
IBM has raised its full-year guidance, now forecasting constant-currency revenue growth of 4 to 5 percent. Management is betting that AI demand and the integration of HashiCorp — acquired last year — will offset the mainframe slump. The generative AI order book has already surpassed $12.5 billion in early 2026, suggesting the pipeline is real.
IBM at a turning point? This analysis reveals what investors need to know now.
Yet the market remains unconvinced. The preliminary second-quarter numbers weren't catastrophic, but they revealed a company whose hardware cycles — particularly the late-stage Z-mainframe cycle — can inflict serious damage. The next major catalyst is the quarterly dividend of $1.69 per share, payable September 10 to shareholders of record on August 10. After that, all eyes turn to the October earnings report, which will test whether HashiCorp integration and the expansion of the agentic AI portfolio can finally smooth out the infrastructure volatility.
For now, IBM is a tale of two businesses: one growing steadily in software, the other trapped in a hardware downdraft. The $10 billion quantum bet adds a third, far more speculative chapter — one that will take years to write. Whether the current oversold condition marks a genuine bottom or just a pause before further declines depends on which story ultimately prevails.
Ad
IBM Stock: New Analysis - 23 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
